Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Medidata a provider of cloud-based solutions for clinical research in life sciences, has announced results of a research study on the impact of protocol changes made while a clinical trial is underway, conducted with the Tufts Center for the Study of...
read more
WuXi AppTec an open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and medical device industries, has announced that WuXi Lab Testing Division (LTD)'s late-and commercial-stage analytical and ...
read more
The contract development and manufacturing organization, Recipharm AB has completed the acquisition of a majority stake in Nitin Lifesciences Limited, an Indian sterile injectables CMO, currently owned by the Sobti family.
read more
Diversis Capital, LLC, a Los Angeles-based private equity firm focused on acquiring and growing small- and middle-market companies, today announced that it has acquired the majority of the assets of Caligor Rx, Inc.
read more
Laboratory Corporation of America has announced that Jonathan Zung, Ph.D., has been named group president, Clinical Development & Commercialization Services for Covance Drug Development.
read more
Juno Therapeutics, a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, and WuXi AppTec, an open-access R&D capability and technology platform company serving the pharmaceutical, ...
read more
CPC Scientific has announced that the CPC Good Manufacturing Practice (GMP) facility in Hangzhou, China has successfully passed its fourth U.S. Food and Drug Administration (FDA) inspection. No Form 483 observations were issued.
read more
WellSpring Pharma Services, a specialist in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3 million capital investment in new equipment as well as a new strategic ...
read more
Wednesday, April 06, 2016
Pfizer has announced that the merger agreement between Pfizer and Allergan has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the ...
read more
Wednesday, April 06, 2016
PGI Drug Discovery has announced that a compound identified through its drug discovery collaboration with Sunovion Pharmaceuticals Inc. has achieved a milestone.
read more
Wednesday, April 06, 2016
Aesica Pharmaceuticals has announced the doubling of its development capacity - manufacturing multiple drug products up to Phase III clinical trials at Queenborough.
read more
Wednesday, April 06, 2016
The U.S. Food and Drug Administration has approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA.
read more
Wednesday, April 06, 2016
Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, has added Tricia A. Bland to its management team as the Executive Director, Strategic ...
read more
Rich Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, has retained the services of an Asian contract research organization CMIC Asia-Pacific, Pte. Ltd., to run Rich's upcoming ...
read more
Pharmaceutical Product Development, LLC (PPD) was named the Best Contract Research Organization (CRO) at the 9th Vaccine Industry Excellence Awards at the World Vaccine Congress 2016. The ViE awards celebrate the outstanding achievements of leaders ...
read more